Aetiological factors behind adipose tissue inflammation: An unexplored research area

Public Health Nutrition

Volumn 16, Issue 1, 2014, Pages 27-35

  Von Scholten, Bernt J ^a   Andresen, Erik N ^a   Sorensen, Thorkild Ia ^a   Jess, Tine ^a,b  

^a The Capital Region   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

Aetiology; Environment; Genes; Inflammation; Obesity

Indexed keywords

ADENOVIRIDAE;

FTO PROTEIN, HUMAN; LEPTIN RECEPTOR; MC4R PROTEIN, HUMAN; MELANOCORTIN 4 RECEPTOR; PROTEIN; TRANS FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; ADIPOSE TISSUE; ENVIRONMENT; FAT INTAKE; GASTROINTESTINAL TRACT; GENETICS; HUMAN; INFLAMMATION; METAGENOME; MICROBIOLOGY; OBESITY; REVIEW; VIROLOGY;

ADENOVIRIDAE; ADIPOSE TISSUE; DIETARY FATS; ENVIRONMENT; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATION; METAGENOME; OBESITY; PROTEINS; RECEPTOR, MELANOCORTIN, TYPE 4; RECEPTORS, LEPTIN; TRANS FATTY ACIDS; TUMOR NECROSIS FACTOR-ALPHA;

MLCS; MLOWN;

EID: 84879481649     PISSN: 13689800     EISSN: 14752727     Source Type: Journal    
DOI: 10.1017/S1368980012000894     Document Type: Review

References (85)

1. Hoppmann J, Perwitz N, Meier B et al. (2010) The balance between gluco-and mineralo-corticoid action critically determines inflammatory adipocyte responses. J Endocrinol 204, 153-164.
2. Zimmermann E, Anty R, Tordjman J et al. (2011) C-reactive protein levels in relation to various features of nonalcoholic fatty liver disease among obese patients. J Hepatol 55, 660-665.
3. Wang Z & Nakayama T (2010) Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm 2010, 535918.
4. Kelley-Hedgepeth A, Lloyd-Jones DM, Colvin A et al. (2008) Ethnic differences in C-reactive protein concentrations. Clin Chem 54, 1027-1037.
5. Khera A, McGuire D, Murphy S et al. (2005) Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 46, 464-469.
6. Florez H, Castillo-Florez S, Mendez A et al. (2006) C-reactive protein is elevated in obese patients with the metabolic syndrome. Diabetes Res Clin Pract 71, 92-100.
7. De Lorenzo A, Del Gobbo V, Premrov MG et al. (2007) Normal-weight obese syndrome: early inflammation Am J Clin Nutr 85, 40-45.
8. Cinti S, Mitchell G, Barbatelli G et al. (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46, 2347-2355.
9. Ö zcan U, Cao Q, Yilmaz E et al. (2004) Endoplasmic reticulum links obesity, insulin action and type 2 diabetes. Science 306, 457-461.
10. Wellen KE & Hotamisligil GS (2003) Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112, 1785-1788.
11. Unger RH, Clark GO, Scherer PE et al. (2010) Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim Biophys Acta 1801, 209-214.
12. Sørensen TIA, Virtue S & Vidal-Puig A (2010) Obesity as a clinical and public health problem: is there a need for a new definition based on lipotoxicity effects Biochim Biophys Acta 1801, 400-404.
13. Eckardt K, Taube A & Eckel J (2011) Obesity-associated insulin resistance in skeletal muscle: role of lipid accumulation and physical inactivity. Rev Endocr Metab Disord 12, 163-172.
14. Dhurandhar N (2001) Infectobesity: obesity of infectious origin. J Nutr 131, issue 10, 2794S-2797S.
15. Suplicy Hde L & Bornschein A (2009) Infections as the etiology for obesity. Arq Bras Endocrinol Metabol 53, 159-164.
16. Atkinson RL (2007) Viruses as an etiology of obesity. Mayo Clin Proc 82, 1192-1198.
17. Na HN, Kim J, Lee HS et al. (2012) Association of human adenovirus-36 in overweight Korean adults. Int J Obes (Lond) 36, 281-285.
18. Bouwman JJ, Visseren FL, Bouter KP et al. (2008) Infectioninduced inflammatory response of adipocytes in vitro. Int J Obes (Lond) 32, 892-901.
19. Dhurandhar NV, Kulkarni PR, Ajinkya SM et al. (1997) Association of adenovirus infection with human obesity. Obes Res 5, 464-469.
20. Thjodleifson B, Olafsson I, Gislason D et al. (2008) Infections and obesity: a multinational epidemiological study. Scand J Infect Dis 40, 381-386.
21. Atkinson RL, Dhurandhar NV, Allison DB et al. (2005) Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes (Lond) 29, 281-286.
22. Whigham LD, Israel BA & Atkinson RL (2006) Adipogenic potential of multiple human adenoviruses in vivo and in vitro in animals. Am J Physiol Regul Integr Comp Physiol 290, R190-R194.
23. So PW, Herlihy AH & Bell JD (2005) Adiposity induced by adenovirus 5 inoculation. Int J Obes (Lond) 29, 603-606.
24. Lyons MJ, Faust IM, Hemmes RB et al. (1982) A virally induced obesity syndrome in mice. Science 216, 82-85.
25. Bernard A, Cohen R, Khuth ST et al. (1999) Alteration of the leptin network in late morbid obesity induced in mice by brain infection with canine distemper virus. J Virol 73, 7317-7327.
26. Carter JK, Ow CL & Smith RE (1983) Rous-associated virus type 7 induces a syndrome in chickens characterized by stunting and obesity. Infect Immun 39, 410-422.
27. Narayan O, Herzog S, Frese K et al. (1983) Behavioral disease in rats caused by immunopathological responses to persistent borna virus in the brain. Science 220, 1401-1403.
28. Gosztonyi G & Ludwig H (1995) Borna disease-neuropathology and pathogenesis. Curr Top Microbiol Immunol 190, 39-73.
29. Hirano N, Kao M & Ludwig H (1983) Persistent, tolerant or subacute infections in Borna disease virus-infected rats. J Gen Virol 64, 1521-1530.
30. Herden C, Herzog S, Richt JA et al. (2000) Distribution of Borna disease virus in the brain of rats infected with an obesity-inducing virus strain. Brain Pathol 10, 39-48.
31. Ludwig H, Bode L & Gosztonyi G (1988) Borna-disease: a persistent virus infection of the central nervous system. Prog Med Virol 35, 107-151.
32. Richt JA, VandeWoude S, Zink MC et al. (1992) Infection with Borna disease virus: molecular and immunobiological characterization of the agent. Clin Infect Dis 14, 1240-1250.
33. de la Torre JC (1994) Molecular biology of Borna disease virus: prototype of a new group of animal viruses. J Virol 68, 7669-7675.
34. Kim YS, Carp RI, Callahan SM et al. (1987) Scrapie-induced obesity in mice. J Infect Dis 156, 402-405.
35. Carp RI, Kim YS & Callahan SM (1990) Pancreatic lesions and hypoglycemia-hyperinsulinemia in scrapie-injected hamsters. J Infect Dis 161, 462-466.
36. DiBaise JK, Zhang H, Crowell MD et al. (2008) Gut microbiota and its possible relationship with obesity. Mayo Clin Proc 83, 460-469.
37. Gill SR, Pop M, Deboy RT et al. (2006) Metagenomic analysis of the human distal gut microbiome. Science 312, 1355-1359.
38. Eckburg PB, Bik EM, Bernstein CN et al. (2005) Diversity of the human intestinal microbial flora. Science 308, 1635-1638.
39. Ley RE, Bäckhed F, Turnbaugh P et al. (2005) Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102, 11070-11075.
40. Frank DN, St Amand AL, Feldman RA et al. (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel disease. Proc Natl Acad Sci USA 104, 13780-13785.
41. Bäckhed F, Ding H, Wang T et al. (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101, 15718-15723.
42. Bäckhed F, Manchester JK, Semenkovich CF et al. (2007) Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 104, 979-984.
43. Turnbaugh PJ, Ley RE, Mahowald MA et al. (2006) An obesity associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031.
44. Topping DL & Clifton PM (2001) Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 81, 1031-1064.
45. Ley RE, Bäckhed F, Turnbaugh P et al. (2005) Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102, 11070-11075.
46. Maslowski KM, Vieira AT, Ng A et al. (2009) Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461, 1282-1286.
47. Cani PD, Amar J, Iglesias MA et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761-1772.
48. Ley RE, Turnbaugh PJ, Klein S et al. (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-1023.
49. Turnbaugh PJ, Hamady M, Yatsunenko T et al. (2009) A core gut microbiome in obese and lean twins. Nature 457, 480-484.
50. Summerbell CD, Douthwaite W, Whittaker V et al. (2009) The association between diet and physical activity and subsequent excess weight gain and obesity assessed at 5 years of age or older: a systematic review of the epidemiological evidence. Int J Obes (Lond) 33, Suppl. 3, S1-S92.
51. Jeffery RW & French SA (1998) Epidemic obesity in the United States: are fast-foods and television viewing contributing Am J Public Health 88, 277-280.
52. Ball K, Brown W & Crawford D (2002) Who does not gain weight Prevalence and predictors of weight maintenance in young women. Int J Obes Relat Metab Disord 26, 1570-1578.
53. Pereira MA, Kartashov AI, Ebbeling CB et al. (2005) Fastfood habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis. Lancet 365, 36-42.
54. French SA, Harnack L & Jeffery RW (2000) Fast food restaurant use among women in the Pound of Prevention study: dietary, behavioral and demographic correlates. Int J Obes Relat Metab Disord 24, 1353-1359.
55. Owen CG, Martin RM, Whincup PH et al. (2005) Effect of infant feeding in the risk of obesity across the life course: a quantitative review of published evidence. Pediatrics 115, 1367-1377.
56. Arenz S, Rückerl R, Koletzko B et al. (2004) Breastfeeding and childhood obesity-a systematic review. Int J Obes Relat Metab Disord 28, 1247-1256.
57. Lundman P, Boquist S, Samnega°rd A et al. (2007) A high-fat meal is accompanied by increased plasma interleukin-6 concentrations. Nutr Metab Cardiovasc Dis 17, 195-202.
58. Micha R & Mozaffarian D (2008) Trans fatty acids: effects on cardiometabolic health and implications for policy. Prostaglandins Leukot Essent Fatty Acids 79, 147-152.
59. Nielsen BM, Nielsen MM, Jakobsen MU et al. (2011) A cross-sectional study on trans-fatty acids and risk markers of CHD among middle-aged men representing a broad range of BMI. Br J Nutr 106, 1245-1252.
60. Micallef MA & Garg ML (2009) Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals. Atherosclerosis 204, 476-482.
61. Fan E, Zhang L, Jiang S et al. (2008) Beneficial effects of resveratrol on atherosclerosis. J Med Food 11, 610-614.
62. Baile CA, Yang J-Y, Rayalam S et al. (2011) Effect of resveratrol on fat mobilisation. Ann N Y Acad Sci 1215, 40-47.
63. North CJ, Venter CS & Jerling JC (2009) The effects of dietary fibres on C-reactive protein, an inflammation marker predicting cardiovascular disease. Eur J Clin Nutr 63, 921-933.
64. Nicklas BJ, Ambrosius W, Messier SP et al. (2004) Dietinduced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial. Am J Clin Nutr 79, 544-551.
65. Andersson J, Boman K, Jansson JH et al. (2008) Effect of intensive lifestyle intervention on C-reactive protein in subjects with impaired glucose tolerance and obesity. Results from a randomized controlled trial with 5-year follow-up. Biomarkers 13, 671-679.
66. Lin CY, Chen PC, Kuo HK et al. (2010) Effects of obesity, physical activity, and cardiorespiratory fitness on blood pressure, inflammation, and insulin resistance in the national health and nutrition survey 1999-2002. Nutr Metab Cardiovasc Dis 20, 713-719.
67. Wärnberg J, Cunningham K, Romeo J et al. (2010) Physical activity, exercise and low-grade systemic inflammation. Proc Nutr Soc 69, 400-406.
68. Ichihara S & Yamada Y (2008) Genetic factors for human obesity. Cell Mol Life Sci 65, 1086-1098.
69. Sørensen TIA, Price RA, Stunkard AJ et al. (1989) Genetics of obesity in adult adoptees and their biological siblings. BMJ 298, 87-90.
70. Stunkard AJ, Sørensen TIA, Hanis C et al. (1986) An adoption study of human obesity. N Engl J Med 314, 193-198.
71. Loos RJ & Bouchard C (2008) FTO: the first gene contributing to common forms of human obesity. Obes Rev 9, 246-250.
72. Andreasen CH & Andersen G (2009) Gene-environment interactions and obesity-further aspects of genome wide association studies. Nutrition 25, 998-1003.
73. Herbert A (2008) The fat tail of obesity as told by the genome. Curr Opin Clin Nutr Metab Care 11, 366-370.
74. Qi L & Cho YA (2008) Gene-environment interaction and obesity. Nutr Rev 66, 684-694.
75. Frayling TM, Timpson NJ, Weedon MN et al. (2007) A common variant in the FTO gene is associated with BMI and predisposes to childhood and adult obesity. Science 316, 889-894.
76. Fisher E, Schulze MB, Stefan N et al. (2009) Association of the FTO rs9939609 single nucleotide polymorphism with C-reactive protein levels. Obesity (Silver Spring) 17, 330-334.
77. Zimmermann E, Skogstrand K, Hougaard DM et al. (2011) Influences of the common FTO rs9939609 variant on inflammatory markers throughout a broad range of body mass index. PLoS One 6, e15958.
78. Chambers JC, Elliott P, Zabaneh D et al. (2008) Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat Genet 40, 716-718.
79. Trevaskis JL, Gawronska-Kozak B, Sutton GM et al. (2007) Role of adiponectin and inflammation in insulin resistance of Mc3r and Mc4r knockout mice. Obesity (Silver Spring) 15, 2664-2672.
80. Brand E, Schorr U, Kunz I et al. (2001) Tumor necrosis factor-a-308 G/A polymorphism in obese Caucasians. Int J Obes Relat Metab Disord 25, 581-585.
81. Sookoian SC, González C & Pirola CJ (2005) Meta-analysis on the G-308A tumor necrosis factor a gene variant and phenotypes associated with the metabolic syndrome. Obes Res 13, 2122-2131.
82. Bochud M, Marquant F, Marques-Vidal PM et al. (2009) Association between C-reactive protein and adiposity in women. J Clin Endocrinol Metab 94, 3969-3977.
83. Ridker PM, Pare G, Parker A et al. (2008) Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R and GCKR associate with plasma C-reactive protein: The Women's Genome Health Study. Am J Hum Genet 82, 1185-1192.
84. Zhang YY, Gottardo L, Mlynarski W et al. (2007) Genetic variability at the leptin receptor (LEPR) locus is a determinant of plasma fibrinogen and C-reactive protein levels. Atherosclerosis 191, 121-127.
85. Olsen LW, Baker JL, Holst C et al. (2006) Birth cohort effect on the obesity epidemic in Denmark. Epidemiology 17, 292-295.